feed,title,long_url,short_url
Benzinga,"DexCom Revises 2025 Outlook, Announces New Product For Diabetics",https://benzinga.com/markets/equities/23/06/33001382/dexcom-revises-2025-outlook-announces-new-product-for-diabetics,https://da.gd/IF7A
Benzinga,DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement,https://benzinga.com/general/biotech/23/06/33003704/dss-inc-is-spinning-off-its-biotech-subsidiary-after-signing-a-major-licensing-agreement,https://da.gd/DuhK3
